Using ketamine in treatment resistant depress...

Prof. Klaus Ebmeier is the Foundation Chair of Old Age Psychiatry. In this interview he gives his point of view on dementia, normal aging and why new treatments are not yet effective. He also explains why failure is the bread-and-butter of research and gives valuable advice to fu ...  Show more

An interview with Professor Phil Burnet, who discusses his research into the influence of the gut microbiome on brain health. He talks about novel findings, potential future work, and takes questions from trainee psychiatrists and researchers. 

One week ago, Matthew Perry’s autopsy report came back, finding that the ‘Friends’ actor died from the acute effects of ketamine overdose. His death has sharpened focus on the popular and controversial drug. Ketamine has been hailed as a miracle cure for depression and anxiety, c ...  Show more

Dr. John Krystal, a leading psychiatrist and neuroscientist, explains how ketamine works in the brain, why it’s revolutionizing depression treatment, and what the future holds for psychedelic-assisted therapy. His journey to discovering the revolutionary benefits of Ketamine trea ...  Show more

New developments in actor Matthew Perry’s death are shining a light on the ethics and efficacy of using ketamine as a therapeutic drug. To learn more about the promise and pitfalls of ketamine treatment, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta turns to David Feifel, on ...  Show more

In this episode Michelle interviews Dr. Steve Thayer, a clinical psychologist at Cedar Psychiatry, about his work using psychotherapy in conjunction with ketamine, a legal and safe psychedelic substance. Michelle shares her personal experience with Dr. Thayer when she participate ...  Show more